Closed-loop tES-non-invasive Stimulation
CLIBM
Closed-loop Non-invasive Stimulation for Improving Brain and Mental Health in Healthy Individuals
1 other identifier
interventional
30
1 country
1
Brief Summary
The goal of this study is to establish if non-invasive closed-loop neuromodulation is an effective approach to enhance cognitive function in healthy 18-40 years old volunteers. The main questions it aims to answer are:
- Can closed-loop stimulation increase stimulation effectiveness?
- Can closed-loop focused ultrasound specifically engage with excitatory or inhibitory neural populations in the target structure as measured through MRS?
- Can observed stimulation outcomes for FUS be predicted through connectome analysis and computational models of indirect changes? Researchers will compare different closed-loop options to their open-loop counterpart to see if closed-loop approaches can increase efficacy and reduce the variability of the stimulation compared to open-loop approaches. Participants will:
- Answer some questionnaires at the start of the study and after each intervention session.
- Undertake a MRI scanning session.
- Undertake one open-loop FUS session.
- Undertake one tES session.
- Undertake one closed-loop FUS sessions involving tES and FUS, followed by a MRI scanning
- Undertake one sham FUS session
- Attend one visit in person to assess eligibility through questionnaires and one cognitive task
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2026
CompletedFirst Posted
Study publicly available on registry
June 26, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
June 26, 2026
June 1, 2026
1.1 years
June 22, 2026
June 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Change from Baseline in EEG Power in Alpha Band (8-12Hz)
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Change from Baseline in EEG Power in Theta Band (4-7Hz)
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Change from Baseline in EEG Power in Beta Band (13-30Hz)
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Change from Baseline in EEG Power in Gamma Band (31-45Hz)
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Changes from Baseline in EEG-derived spectral power
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Changes from Baseline in Functional connectivity (e.g., through changes in Phase-locked value (PLV))
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Average Reaction time (ms) measured from the Visual Working memory task
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Average Overall accuracy (%) measured from Visual Working Memory task
Baseline to 10 weeks, measured immediately before, during, and immediately after stimulation
Change from Baseline in Target-Region metabolite Concentration measured via Magnetic Resonance Spectroscopy (MRS)
Baseline (Day 1) to immediately after closed-loop post-stimulation intervention
Changes from Baseline in Functional Connectivity calculated from functional Magnetic Resonance Imaging (fMRI)
Baseline (Day 1) to immediately after closed-loop post-stimulation intervention
Changes from Baseline on Structural connectivity metrics derived from multi-shell diffusion MRI (dMRI) tractography
Baseline (Day 1) to immediately after closed-loop post-stimulation intervention
Secondary Outcomes (1)
Structured questionnaire assessing adverse effects of the intervention
Immediately after stimulation, 24 hours after stimulation and 1 week after stimulation
Study Arms (4)
Open-loop transcranial low-intensity FUS
ACTIVE COMPARATORTranscranial low intensity focused ultrasound stimulation (FUS) with 500kHz transducer for following either the continuous theta burst or intermittent theta burst protocol using the NeuroFus PRO system
Closed-loop transcranial low-intensity FUS
EXPERIMENTALClosed-loop Transcranial Electrical Stimulation by means of tACS or TI delivered through a Digitimer DS5 for brain entrainment phase-locked on peak or trough to transcranial low intensity FUS delivered to dACC through the NeuroFUS PRO system
tES alone
ACTIVE COMPARATORtACS or TI delivered through a Digitimer DS5 for brain entrainment phase-locked on peak or trough
Sham FUS
ACTIVE COMPARATORFUS delivered to ventricles or FUS and tACS located on head, one of them on or off depending on sham, or active.
Interventions
We obtain baseline functional, metabolic and structural information through MRI and MRS scanning
Low intensity focused ultrasound stimulation (FUS) with 500kHz transducer for following either the continuous theta burst or intermittent theta burst protocol using the NeuroFus PRO system
Transcranial electrical stimulation (by means of transcranial alternating current stimulation (tACS) or non-invasive temporal interference (TI) electrical stimulation) using the DS5 isolated bipolar constant current stimulator together connected to a wave generator and with two electrodes for tACS (TI implementation will be carried out with two DS5 systems, separate wave generators and four electrodes).
Eligibility Criteria
You may qualify if:
- Participant is willing and able to give informed consent for participation in the study
- Aged between 18 and 40
- Good general health
- Not consume alcohol 48 hours prior study visit
- Not currently taking any medications (except contraceptive pills) or if on long-term medication for a non-neurological/non-psychiatric condition (r.g. inhalers) to be considered otherwise healthy and stable with no symptoms
- Be right handedness
You may not qualify if:
- Inability to complete MRI/FUS/TMS/tES safety questionnaire and / or informed consent process.
- Current or previous diagnosis of a neurological, neurosurgical, psychiatric disorders.
- Currently pregnant, breast feeding, or on planned pregnancy.
- Medication intake (such as beta-blocker, glucocorticoids, anti-depressants, anti-inflammatory drugs in the last 7d).
- Medication intake (such as beta-blocker, glucocorticoids, anti-depressants) in the last 7d that are likely to affect brain function.
- Significant use of medication or recreational drugs that affect the nervous system.
- Excessive consumption of alcohol (\>2 alcohol beverages per day).
- Known allergy to any required consumables (such as aquasonic gel).
- History of anaphylaxis to any substance
- Have tightly coiled, curly or voluminous texture hair type (e.g., hair type 3, 4, or afro hair).
- Having skin disease or sensitive skin on or close to the head.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Nottingham
Nottingham, United Kingdom
Related Publications (7)
Zhai Z, Ren L, Song Z, Xiang Q, Zhuo K, Zhang S, Li X, Zhang Y, Jiao X, Tong S, Sun J, Liu D. The efficacy of low-intensity transcranial ultrasound stimulation on negative symptoms in schizophrenia: A double-blind, randomized sham-controlled study. Brain Stimul. 2023 May-Jun;16(3):790-792. doi: 10.1016/j.brs.2023.04.021. Epub 2023 Apr 29. No abstract available.
PMID: 37121354BACKGROUNDSarica C, Nankoo JF, Fomenko A, Grippe TC, Yamamoto K, Samuel N, Milano V, Vetkas A, Darmani G, Cizmeci MN, Lozano AM, Chen R. Human Studies of Transcranial Ultrasound neuromodulation: A systematic review of effectiveness and safety. Brain Stimul. 2022 May-Jun;15(3):737-746. doi: 10.1016/j.brs.2022.05.002. Epub 2022 May 6.
PMID: 35533835BACKGROUNDRaco V, Bauer R, Tharsan S, Gharabaghi A. Combining TMS and tACS for Closed-Loop Phase-Dependent Modulation of Corticospinal Excitability: A Feasibility Study. Front Cell Neurosci. 2016 May 25;10:143. doi: 10.3389/fncel.2016.00143. eCollection 2016.
PMID: 27252625BACKGROUNDBriley PM, Boutry C, Webster L, Veniero D, Harvey-Seutcheu C, Jung J, Liddle PF, Morriss R. Intermittent theta burst stimulation with synchronised transcranial alternating current stimulation leads to enhanced frontal theta oscillations and a positive shift in emotional bias. Imaging Neurosci (Camb). 2024 Jan 25;2:imag-2-00073. doi: 10.1162/imag_a_00073. eCollection 2024.
PMID: 40800403BACKGROUNDNakazono H, Ogata K, Takeda A, Yamada E, Oka S, Tobimatsu S. A specific phase of transcranial alternating current stimulation at the beta frequency boosts repetitive paired-pulse TMS-induced plasticity. Sci Rep. 2021 Jun 23;11(1):13179. doi: 10.1038/s41598-021-92768-x.
PMID: 34162993BACKGROUNDZrenner C, Desideri D, Belardinelli P, Ziemann U. Real-time EEG-defined excitability states determine efficacy of TMS-induced plasticity in human motor cortex. Brain Stimul. 2018 Mar-Apr;11(2):374-389. doi: 10.1016/j.brs.2017.11.016. Epub 2017 Nov 24.
PMID: 29191438BACKGROUNDGold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res. 2004 Dec 15;72(1):21-8. doi: 10.1016/j.schres.2004.09.008.
PMID: 15531404BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marcus Kaiser, PhD
University of Nottingham
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Neuroinformatics
Study Record Dates
First Submitted
June 22, 2026
First Posted
June 26, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
June 26, 2026
Record last verified: 2026-06